HEADER IMMUNE SYSTEM 27-OCT-16 5TRZ TITLE CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF TITLE 2 MYCOBACTERIAL TUBERCULOSIS (YQSGLSIVM) COMPND MOL_ID: 1; COMPND 2 MOLECULE: H-2 CLASS I HISTOCOMPATIBILITY ANTIGEN, K-D ALPHA CHAIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: UNP RESIDUES 23-297; COMPND 5 SYNONYM: H-2K(D); COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 9 CHAIN: B, D; COMPND 10 FRAGMENT: UNP RESIDUES 21-119; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: PEPTIDE (P9) OF MTB85B (MYCOBACTERIUM TUBERCULOSIS) COMPND 14 YQSGLSIVM; COMPND 15 CHAIN: P, Q; COMPND 16 FRAGMENT: UNP RESIDUES 102-110; COMPND 17 SYNONYM: DGAT,30 KDA EXTRACELLULAR PROTEIN,ACYL-COA:DIACYLGLYCEROL COMPND 18 ACYLTRANSFERASE,ANTIGEN 85 COMPLEX B,AG85B,EXTRACELLULAR ALPHA- COMPND 19 ANTIGEN,FIBRONECTIN-BINDING PROTEIN B,FBPS B; COMPND 20 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: H2-K1, H2-K; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21-B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET3A; SOURCE 21 MOL_ID: 3; SOURCE 22 SYNTHETIC: YES; SOURCE 23 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 24 ORGANISM_TAXID: 83332 KEYWDS MAJOR HISTOMPATIBILITY COMPLEX CLASS I, MHC-I, H2-KD, H-2KD, KEYWDS 2 MYCOBACTERIAL TUBERCULOSIS, TB PEPTIDE, MTB85B, MTB85A, MKAN85B, KEYWDS 3 IMMUNE RESPONSE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.JIANG,K.NATARAJAN,D.MARGULIES REVDAT 2 14-AUG-19 5TRZ 1 JRNL REVDAT 1 09-MAY-18 5TRZ 0 JRNL AUTH S.KOMINE-AIZAWA,J.JIANG,S.MIZUNO,S.HAYAKAWA,K.MATSUO, JRNL AUTH 2 L.F.BOYD,D.H.MARGULIES,M.HONDA JRNL TITL MHC-RESTRICTED AG85B-SPECIFIC CD8+T CELLS ARE ENHANCED BY JRNL TITL 2 RECOMBINANT BCG PRIME AND DNA BOOST IMMUNIZATION IN MICE. JRNL REF EUR.J.IMMUNOL. 2019 JRNL REFN ISSN 0014-2980 JRNL PMID 31135967 JRNL DOI 10.1002/EJI.201847988 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.10.1_2155 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.00 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 41174 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.198 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 2065 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.0000 - 5.6178 0.94 2682 142 0.2108 0.2306 REMARK 3 2 5.6178 - 4.4601 0.95 2632 138 0.1482 0.1746 REMARK 3 3 4.4601 - 3.8966 0.95 2612 138 0.1333 0.1606 REMARK 3 4 3.8966 - 3.5405 0.95 2634 138 0.1484 0.1623 REMARK 3 5 3.5405 - 3.2868 0.95 2612 138 0.1528 0.1876 REMARK 3 6 3.2868 - 3.0931 0.95 2601 137 0.1673 0.2109 REMARK 3 7 3.0931 - 2.9382 0.95 2593 136 0.1712 0.2133 REMARK 3 8 2.9382 - 2.8103 0.95 2645 139 0.1849 0.2274 REMARK 3 9 2.8103 - 2.7021 0.94 2577 136 0.1860 0.2153 REMARK 3 10 2.7021 - 2.6089 0.95 2595 137 0.1906 0.2453 REMARK 3 11 2.6089 - 2.5273 0.95 2602 137 0.2019 0.2270 REMARK 3 12 2.5273 - 2.4551 0.95 2562 134 0.2025 0.2834 REMARK 3 13 2.4551 - 2.3905 0.94 2615 138 0.2207 0.2195 REMARK 3 14 2.3905 - 2.3321 0.95 2536 133 0.2150 0.2486 REMARK 3 15 2.3321 - 2.2791 0.92 2604 138 0.2290 0.2903 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.38 REMARK 3 B_SOL : 43.90 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.890 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 6524 REMARK 3 ANGLE : 0.796 8854 REMARK 3 CHIRALITY : 0.049 899 REMARK 3 PLANARITY : 0.006 1151 REMARK 3 DIHEDRAL : 19.828 3820 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TRZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1000224689. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0333 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX300HE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41174 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 47.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.97200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% PEG 4000, 0.1M MES BUFFER, 5% MPD, REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.40800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 13420 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P, C, D, Q REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 89 CG CD CE NZ REMARK 470 LEU A 219 CG CD1 CD2 REMARK 470 GLU A 222 CG CD OE1 OE2 REMARK 470 ASP A 223 CG OD1 OD2 REMARK 470 LEU A 224 CG CD1 CD2 REMARK 470 ASP A 227 CG OD1 OD2 REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 LYS B 48 CG CD CE NZ REMARK 470 ARG C 83 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 89 CG CD CE NZ REMARK 470 SER C 105 OG REMARK 470 ASN C 220 CG OD1 ND2 REMARK 470 GLU C 222 CG CD OE1 OE2 REMARK 470 ASP C 223 CG OD1 OD2 REMARK 470 LEU C 224 CB CG CD1 CD2 REMARK 470 THR C 225 OG1 REMARK 470 ASP C 227 CG OD1 OD2 REMARK 470 GLN C 255 CG CD OE1 NE2 REMARK 470 LYS C 275 CG CD CE NZ REMARK 470 LYS D 48 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH C 402 O HOH C 474 2.08 REMARK 500 O HOH B 205 O HOH B 232 2.09 REMARK 500 O HOH C 427 O HOH C 438 2.12 REMARK 500 O HOH A 452 O HOH A 490 2.14 REMARK 500 O HOH C 421 O HOH C 461 2.14 REMARK 500 O HOH A 430 O HOH A 492 2.14 REMARK 500 O HOH A 443 O HOH A 492 2.16 REMARK 500 ND2 ASN D 17 OE1 GLU D 74 2.16 REMARK 500 O HOH C 401 O HOH C 465 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH P 108 O HOH Q 102 1545 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -123.86 55.19 REMARK 500 TYR A 123 -72.14 -115.91 REMARK 500 ASN A 220 -107.18 57.13 REMARK 500 GLU A 222 34.25 -91.22 REMARK 500 LEU A 224 -173.60 -62.17 REMARK 500 TRP B 60 -1.19 84.47 REMARK 500 LEU P 5 -97.44 -104.21 REMARK 500 ASP C 29 -123.80 55.62 REMARK 500 TYR C 123 -72.92 -116.52 REMARK 500 GLN C 218 100.25 33.34 REMARK 500 ASN C 220 11.10 53.05 REMARK 500 ASP C 223 -40.48 60.58 REMARK 500 SER D 57 -167.21 -78.91 REMARK 500 TRP D 60 -0.39 85.80 REMARK 500 LEU Q 5 -95.45 -104.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO C 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO C 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO C 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO C 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO C 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO D 101 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TS1 RELATED DB: PDB DBREF 5TRZ A 2 276 UNP P01902 HA1D_MOUSE 23 297 DBREF 5TRZ B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 5TRZ P 1 9 UNP P9WQP1 A85B_MYCTU 102 110 DBREF 5TRZ C 2 276 UNP P01902 HA1D_MOUSE 23 297 DBREF 5TRZ D 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 5TRZ Q 1 9 UNP P9WQP1 A85B_MYCTU 102 110 SEQADV 5TRZ HIS A 114 UNP P01902 GLN 135 CONFLICT SEQADV 5TRZ PRO A 276 UNP P01902 LEU 297 CONFLICT SEQADV 5TRZ MET B 0 UNP P61769 INITIATING METHIONINE SEQADV 5TRZ HIS C 114 UNP P01902 GLN 135 CONFLICT SEQADV 5TRZ PRO C 276 UNP P01902 LEU 297 CONFLICT SEQADV 5TRZ MET D 0 UNP P61769 INITIATING METHIONINE SEQRES 1 A 275 PRO HIS SER LEU ARG TYR PHE VAL THR ALA VAL SER ARG SEQRES 2 A 275 PRO GLY LEU GLY GLU PRO ARG PHE ILE ALA VAL GLY TYR SEQRES 3 A 275 VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP ALA SEQRES 4 A 275 ASP ASN PRO ARG PHE GLU PRO ARG ALA PRO TRP MET GLU SEQRES 5 A 275 GLN GLU GLY PRO GLU TYR TRP GLU GLU GLN THR GLN ARG SEQRES 6 A 275 ALA LYS SER ASP GLU GLN TRP PHE ARG VAL SER LEU ARG SEQRES 7 A 275 THR ALA GLN ARG TYR TYR ASN GLN SER LYS GLY GLY SER SEQRES 8 A 275 HIS THR PHE GLN ARG MET PHE GLY CYS ASP VAL GLY SER SEQRES 9 A 275 ASP TRP ARG LEU LEU ARG GLY TYR HIS GLN PHE ALA TYR SEQRES 10 A 275 ASP GLY ARG ASP TYR ILE ALA LEU ASN GLU ASP LEU LYS SEQRES 11 A 275 THR TRP THR ALA ALA ASP THR ALA ALA LEU ILE THR ARG SEQRES 12 A 275 ARG LYS TRP GLU GLN ALA GLY ASP ALA GLU TYR TYR ARG SEQRES 13 A 275 ALA TYR LEU GLU GLY GLU CYS VAL GLU TRP LEU ARG ARG SEQRES 14 A 275 TYR LEU GLU LEU GLY ASN GLU THR LEU LEU ARG THR ASP SEQRES 15 A 275 SER PRO LYS ALA HIS VAL THR TYR HIS PRO ARG SER GLN SEQRES 16 A 275 VAL ASP VAL THR LEU ARG CYS TRP ALA LEU GLY PHE TYR SEQRES 17 A 275 PRO ALA ASP ILE THR LEU THR TRP GLN LEU ASN GLY GLU SEQRES 18 A 275 ASP LEU THR GLN ASP MET GLU LEU VAL GLU THR ARG PRO SEQRES 19 A 275 ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL VAL SEQRES 20 A 275 VAL PRO LEU GLY LYS GLU GLN ASN TYR THR CYS HIS VAL SEQRES 21 A 275 HIS HIS LYS GLY LEU PRO GLU PRO LEU THR LEU ARG TRP SEQRES 22 A 275 LYS PRO SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 P 9 TYR GLN SER GLY LEU SER ILE VAL MET SEQRES 1 C 275 PRO HIS SER LEU ARG TYR PHE VAL THR ALA VAL SER ARG SEQRES 2 C 275 PRO GLY LEU GLY GLU PRO ARG PHE ILE ALA VAL GLY TYR SEQRES 3 C 275 VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP ALA SEQRES 4 C 275 ASP ASN PRO ARG PHE GLU PRO ARG ALA PRO TRP MET GLU SEQRES 5 C 275 GLN GLU GLY PRO GLU TYR TRP GLU GLU GLN THR GLN ARG SEQRES 6 C 275 ALA LYS SER ASP GLU GLN TRP PHE ARG VAL SER LEU ARG SEQRES 7 C 275 THR ALA GLN ARG TYR TYR ASN GLN SER LYS GLY GLY SER SEQRES 8 C 275 HIS THR PHE GLN ARG MET PHE GLY CYS ASP VAL GLY SER SEQRES 9 C 275 ASP TRP ARG LEU LEU ARG GLY TYR HIS GLN PHE ALA TYR SEQRES 10 C 275 ASP GLY ARG ASP TYR ILE ALA LEU ASN GLU ASP LEU LYS SEQRES 11 C 275 THR TRP THR ALA ALA ASP THR ALA ALA LEU ILE THR ARG SEQRES 12 C 275 ARG LYS TRP GLU GLN ALA GLY ASP ALA GLU TYR TYR ARG SEQRES 13 C 275 ALA TYR LEU GLU GLY GLU CYS VAL GLU TRP LEU ARG ARG SEQRES 14 C 275 TYR LEU GLU LEU GLY ASN GLU THR LEU LEU ARG THR ASP SEQRES 15 C 275 SER PRO LYS ALA HIS VAL THR TYR HIS PRO ARG SER GLN SEQRES 16 C 275 VAL ASP VAL THR LEU ARG CYS TRP ALA LEU GLY PHE TYR SEQRES 17 C 275 PRO ALA ASP ILE THR LEU THR TRP GLN LEU ASN GLY GLU SEQRES 18 C 275 ASP LEU THR GLN ASP MET GLU LEU VAL GLU THR ARG PRO SEQRES 19 C 275 ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL VAL SEQRES 20 C 275 VAL PRO LEU GLY LYS GLU GLN ASN TYR THR CYS HIS VAL SEQRES 21 C 275 HIS HIS LYS GLY LEU PRO GLU PRO LEU THR LEU ARG TRP SEQRES 22 C 275 LYS PRO SEQRES 1 D 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 D 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 D 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 D 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 D 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 D 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 D 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 D 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 Q 9 TYR GLN SER GLY LEU SER ILE VAL MET HET GOL A 301 6 HET EDO A 302 4 HET EDO A 303 4 HET GOL B 101 6 HET GOL C 301 6 HET EDO C 302 4 HET EDO C 303 4 HET EDO C 304 4 HET EDO C 305 4 HET EDO C 306 4 HET EDO D 101 4 HETNAM GOL GLYCEROL HETNAM EDO 1,2-ETHANEDIOL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 7 GOL 3(C3 H8 O3) FORMUL 8 EDO 8(C2 H6 O2) FORMUL 18 HOH *276(H2 O) HELIX 1 AA1 ALA A 49 GLU A 53 5 5 HELIX 2 AA2 GLY A 56 TYR A 85 1 30 HELIX 3 AA3 ASP A 137 GLY A 151 1 15 HELIX 4 AA4 GLY A 151 GLY A 162 1 12 HELIX 5 AA5 GLY A 162 GLY A 175 1 14 HELIX 6 AA6 GLY A 175 LEU A 180 1 6 HELIX 7 AA7 LYS A 253 GLN A 255 5 3 HELIX 8 AA8 ALA C 49 GLU C 55 5 7 HELIX 9 AA9 GLY C 56 TYR C 85 1 30 HELIX 10 AB1 ASP C 137 GLY C 151 1 15 HELIX 11 AB2 GLY C 151 GLY C 162 1 12 HELIX 12 AB3 GLY C 162 GLY C 175 1 14 HELIX 13 AB4 GLY C 175 LEU C 180 1 6 HELIX 14 AB5 LYS C 253 TYR C 257 5 5 SHEET 1 AA1 8 GLU A 46 PRO A 47 0 SHEET 2 AA1 8 THR A 31 ASP A 37 -1 N ARG A 35 O GLU A 46 SHEET 3 AA1 8 GLY A 18 VAL A 28 -1 N VAL A 28 O THR A 31 SHEET 4 AA1 8 HIS A 3 ARG A 14 -1 N THR A 10 O ILE A 23 SHEET 5 AA1 8 THR A 94 VAL A 103 -1 O PHE A 95 N ALA A 11 SHEET 6 AA1 8 LEU A 109 TYR A 118 -1 O LEU A 110 N ASP A 102 SHEET 7 AA1 8 ARG A 121 LEU A 126 -1 O ILE A 124 N PHE A 116 SHEET 8 AA1 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AA2 4 LYS A 186 HIS A 192 0 SHEET 2 AA2 4 ASP A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AA2 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 AA2 4 GLU A 229 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 AA3 4 LYS A 186 HIS A 192 0 SHEET 2 AA3 4 ASP A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AA3 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 AA3 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 AA4 3 THR A 214 LEU A 219 0 SHEET 2 AA4 3 TYR A 257 HIS A 262 -1 O THR A 258 N GLN A 218 SHEET 3 AA4 3 LEU A 270 ARG A 273 -1 O LEU A 272 N CYS A 259 SHEET 1 AA5 4 LYS B 6 SER B 11 0 SHEET 2 AA5 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA5 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 AA5 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 AA6 4 LYS B 6 SER B 11 0 SHEET 2 AA6 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 AA6 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 AA6 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 AA7 4 GLU B 44 ARG B 45 0 SHEET 2 AA7 4 ILE B 35 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 AA7 4 TYR B 78 HIS B 84 -1 O ALA B 79 N LEU B 40 SHEET 4 AA7 4 LYS B 91 LYS B 94 -1 O VAL B 93 N CYS B 80 SHEET 1 AA8 8 GLU C 46 PRO C 47 0 SHEET 2 AA8 8 THR C 31 ASP C 37 -1 N ARG C 35 O GLU C 46 SHEET 3 AA8 8 GLY C 18 VAL C 28 -1 N VAL C 28 O THR C 31 SHEET 4 AA8 8 HIS C 3 ARG C 14 -1 N ARG C 6 O TYR C 27 SHEET 5 AA8 8 THR C 94 VAL C 103 -1 O ARG C 97 N VAL C 9 SHEET 6 AA8 8 LEU C 109 TYR C 118 -1 O LEU C 110 N ASP C 102 SHEET 7 AA8 8 ARG C 121 LEU C 126 -1 O LEU C 126 N HIS C 114 SHEET 8 AA8 8 TRP C 133 ALA C 135 -1 O THR C 134 N ALA C 125 SHEET 1 AA9 4 LYS C 186 HIS C 192 0 SHEET 2 AA9 4 ASP C 198 PHE C 208 -1 O TRP C 204 N HIS C 188 SHEET 3 AA9 4 PHE C 241 PRO C 250 -1 O ALA C 245 N CYS C 203 SHEET 4 AA9 4 MET C 228 LEU C 230 -1 N GLU C 229 O ALA C 246 SHEET 1 AB1 4 LYS C 186 HIS C 192 0 SHEET 2 AB1 4 ASP C 198 PHE C 208 -1 O TRP C 204 N HIS C 188 SHEET 3 AB1 4 PHE C 241 PRO C 250 -1 O ALA C 245 N CYS C 203 SHEET 4 AB1 4 ARG C 234 PRO C 235 -1 N ARG C 234 O GLN C 242 SHEET 1 AB2 3 ILE C 213 THR C 216 0 SHEET 2 AB2 3 CYS C 259 HIS C 263 -1 O HIS C 260 N THR C 216 SHEET 3 AB2 3 LEU C 270 LEU C 272 -1 O LEU C 272 N CYS C 259 SHEET 1 AB3 4 LYS D 6 SER D 11 0 SHEET 2 AB3 4 ASN D 21 PHE D 30 -1 O ASN D 24 N TYR D 10 SHEET 3 AB3 4 PHE D 62 PHE D 70 -1 O THR D 68 N LEU D 23 SHEET 4 AB3 4 GLU D 50 HIS D 51 -1 N GLU D 50 O TYR D 67 SHEET 1 AB4 4 LYS D 6 SER D 11 0 SHEET 2 AB4 4 ASN D 21 PHE D 30 -1 O ASN D 24 N TYR D 10 SHEET 3 AB4 4 PHE D 62 PHE D 70 -1 O THR D 68 N LEU D 23 SHEET 4 AB4 4 SER D 55 PHE D 56 -1 N SER D 55 O TYR D 63 SHEET 1 AB5 4 GLU D 44 ARG D 45 0 SHEET 2 AB5 4 GLU D 36 LYS D 41 -1 N LYS D 41 O GLU D 44 SHEET 3 AB5 4 TYR D 78 ASN D 83 -1 O ARG D 81 N ASP D 38 SHEET 4 AB5 4 LYS D 91 LYS D 94 -1 O LYS D 91 N VAL D 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.02 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 SSBOND 4 CYS C 101 CYS C 164 1555 1555 2.04 SSBOND 5 CYS C 203 CYS C 259 1555 1555 2.02 SSBOND 6 CYS D 25 CYS D 80 1555 1555 2.03 CISPEP 1 TYR A 209 PRO A 210 0 3.83 CISPEP 2 HIS B 31 PRO B 32 0 1.53 CISPEP 3 TYR C 209 PRO C 210 0 4.09 CISPEP 4 HIS D 31 PRO D 32 0 1.25 SITE 1 AC1 5 ASP A 29 ASP A 30 HOH A 405 TYR B 63 SITE 2 AC1 5 GOL B 101 SITE 1 AC2 3 VAL A 231 GLU A 232 GLN B 8 SITE 1 AC3 3 TYR A 118 ARG A 121 ASP A 137 SITE 1 AC4 3 GOL A 301 LYS B 58 HOH B 211 SITE 1 AC5 4 THR C 31 THR C 178 TYR C 209 GLY C 239 SITE 1 AC6 6 ARG A 273 GLU C 173 LEU C 174 ASN C 176 SITE 2 AC6 6 GLU C 177 HOH C 429 SITE 1 AC7 4 HIS C 262 HIS C 263 LEU C 266 PRO C 269 SITE 1 AC8 4 ALA A 150 ALA C 150 GLY C 151 LEU Q 5 SITE 1 AC9 2 ARG C 202 ASP D 96 SITE 1 AD1 4 GLY C 252 LYS C 253 GLU C 254 GLN C 255 SITE 1 AD2 5 ARG C 234 GLN D 8 VAL D 9 MET D 99 SITE 2 AD2 5 HOH D 202 CRYST1 46.635 88.816 110.754 90.00 89.99 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021443 0.000000 -0.000005 0.00000 SCALE2 0.000000 0.011259 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009029 0.00000